Engineering biology is transforming technology and science. Researchers in the international Genome Project-write, including two authors from the UTIA Center for Agricultural Synthetic Biology, outline the technological advances needed to secure a safe, responsible future in the October 18 issue of Science. Photo by T. Salvador, courtesy UTIA.
Engineering biology is already transforming technology and science, and a consortium of researchers across many disciplines in the international Genome Project-write is calling for more discussion among scientists, policy makers and the general public to shepherd future development.
In a policy forum article published in the October 18 issue of Science, the authors outline the technological advances needed to secure the transformative future of synthetic biology and express their concerns that the implementation of the relatively new discipline remains safe and responsible.
Two researchers with the University of Tennessee Institute of Agriculture are co-authors on the piece titled “Technological challenges and milestones for writing genomes: synthetic genomics requires improved technologies.” Neal Stewart and Scott Lenaghan with the UTIA departments of Plant Sciences and Food Science, respectively, join Nili Ostrov, a Ph.D. research fellow in genetics at Harvard Medical School, and 18 other leading scientists from a number of institutions and disciplines, in outlining a potential timeline for the development of what they call transformative advances to science and society.
Stewart and Lenaghan are the co-directors of the UT Center for Agricultural Synthetic Biology (CASB). Formed in 2018, Stewart says CASB is the first synthetic biology center in the world aimed specifically at improved agriculture. A professor of plant sciences in the UT Herbert College of Agriculture, Stewart also holds the endowed Racheff Chair of Excellence in Plant Molecular Genetics. Lenaghan is an assistant professor in the Department of Food Science who also holds an adjunct position in the UT Mechanical, Aerospace, and Biomedical Engineering (MABE) Department.
Synthetic biology uses computational techniques to help scientists identify genes that result in beneficial traits. In agricultural practices, these characteristics can then be triggered so that plant and animal production is improved. In addition to improved biology, Lenaghan hopes the CASB will allow for collaborations to expand the current definition of synthetic biology beyond molecular biology tools, translating advances into synthetic and engineered constructs, such as micro/nanorobots, diagnostic devices and smart materials that can benefit society beyond the food we produce and eat.
The paper’s authors assert, “A highly interdisciplinary, multinational effort from government and private sectors will help achieve and disseminate these advances to make an impact in biomedical, pharmaceutical, agricultural, and chemical industries.”
Emerging technologies and improvements to existing gene synthesis methods are identified and needed, say the paper’s authors, in four major areas to advance synthetic genomics within the next ten years: genome design, DNA synthesis, genome editing, and chromosome construction. But first they say substantial improvements are needed to reduce the cost and increase the speed and reliability of genetic tools.
“In a world that expects to sustain a population of more than 9 billion people by the year 2050, we will have to have more efficient and productive crop production to survive,” asserts Stewart. “Writing whole plant genomes, such as the relatively small one in chloroplasts, could revolutionize crop productivity simply by making photosynthesis more efficient. This roadmap paper tells us how to get there safely.”
Learn more: Tennessee Researchers Join Call for Responsible Development of Synthetic Biology
The Latest on: Synthetic biology
via Google News
The Latest on: Synthetic biology
- Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summiton August 1, 2022 at 5:03 am
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Jim Thorburn, ...
- Absci to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conferenceon August 1, 2022 at 5:03 am
Absci management is scheduled to participate in a fireside chat on Tuesday, August 9th at 3:00 p.m. Pacific Time (6:00 p.m. Eastern Time). Interested parties may access a live and archived webcast of ...
- NSF grant to help Zhang lab build better muscle with synthetic biologyon July 29, 2022 at 9:57 am
Fuzhong Zhang's lab at the McKelvey School of Engineering developed a platform to produce muscle fibers that are strong, tough and can absorb energy in ways very similar to the real thing. With a ...
- The global synthetic biology market is expected to grow at a CAGR of 25% during 2022-2027on July 28, 2022 at 7:55 am
Synthetic biology is a new interdisciplinary field that includes the application of engineering principles to biology. It intends to design and manufacture biological components and systems that do ...
- Synthetic Biology Technology Market Size Future Prospects, Growth, Outlook and Forecast 2028on July 28, 2022 at 5:28 am
The MarketWatch News Department was not involved in the creation of this content. Jul 28, 2022 (Market Insight Reports) -- An analysis of Synthetic Biology Technology market has been provided in the ...
- Synthetic biology startup creates sustainable dyes for blue jeanson July 28, 2022 at 3:53 am
Huue co-founders CEO Michelle Zhu and CTO Tammy Hsu. In 1853, Levi Strauss opened a dry goods shop in San Francisco to earn a living catering to the needs of gold miners who heard the calls of “eureka ...
- Berkeley startup Huue wants to dye your jeans blue with synthetic indigoon July 27, 2022 at 10:40 am
The blue cotton pants have endured as a practical working garment and a fashion staple, but the dying process involves chemicals, raw materials and lots of water. Now a Berkeley s ...
- The FDA needs to get ready to evaluate synthetic cells, the next generation of therapeuticson July 26, 2022 at 1:55 am
Long before the first synthetic cell is tested for treatment, the FDA needs to develop a regulatory framework for this new therapeutic approach. Otherwise, the future of these therapies could be ...
- Synthetic Biology Market a Ray of Hope for Pharma and Food Companies to Revolutionize their Way of Looking at Growth Opportunitieson July 20, 2022 at 7:47 am
Synthetic biology market was valued at USD 9.5 billion in 2020, and it is expected to reach a value of USD 38.7 billion by 2027, at a CAGR of 26.5% over the forecast period (2020–2028).Westford, USA, ...
- eureKARE launches synthetic biology studio networkon July 19, 2022 at 8:24 am
In conjunction with this, eureKARE has appointed Georges Rawadi as chief of biotech studio development. eureKARE said its thematic synthetic biology studio model is a novel, flexible approach to ...
via Bing News